ZYME
Zymeworks Inc

2,590
Mkt Cap
$1.73B
Volume
604,391.00
52W High
$28.49
52W Low
$9.03
PE Ratio
-21.61
ZYME Fundamentals
Price
$23.32
Prev Close
$23.90
Open
$23.80
50D MA
$23.44
Beta
0.96
Avg. Volume
537,880.72
EPS (Annual)
-$1.08
P/B
6.53
Rev/Employee
$401,382.58
$1,775.10
Loading...
Loading...
News
all
press releases
Zymeworks (NASDAQ:ZYME) Trading Up 9.7% - What's Next?
Zymeworks (NASDAQ:ZYME) Shares Up 9.7% - Still a Buy...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
Zymeworks (NASDAQ:ZYME) Price Target Raised to $46.00
HC Wainwright lifted their price target on shares of Zymeworks from $32.00 to $46.00 and gave the stock a "buy" rating in a research report on Friday...
MarketBeat·16d ago
News Placeholder
Zymeworks (NASDAQ:ZYME) Trading 2.8% Higher on Analyst Upgrade
Zymeworks (NASDAQ:ZYME) Trading Up 2.8% on Analyst Upgrade...
MarketBeat·19d ago
News Placeholder
Zymeworks (NASDAQ:ZYME) Price Target Raised to $47.00
Stifel Nicolaus increased their price target on Zymeworks from $40.00 to $47.00 and gave the company a "buy" rating in a research note on Tuesday...
MarketBeat·19d ago
News Placeholder
Leerink Partners Increases Zymeworks (NASDAQ:ZYME) Price Target to $58.00
Leerink Partners boosted their price objective on Zymeworks from $52.00 to $58.00 and gave the stock an "outperform" rating in a research note on Tuesday...
MarketBeat·19d ago
News Placeholder
Zymeworks Q4 Earnings Call Highlights
Zymeworks (NASDAQ:ZYME) executives used the company's fourth-quarter 2025 results call to highlight updated clinical data for its partnered HER2 antibody zanidatamab, outline a new royalty-backed...
MarketBeat·20d ago
News Placeholder
Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates
Zymeworks (ZYME) delivered earnings and revenue surprises of -58.64% and -88.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20d ago
News Placeholder
Zymeworks (NASDAQ:ZYME) Releases Earnings Results, Misses Estimates By $0.20 EPS
Zymeworks (NASDAQ:ZYME - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20...
MarketBeat·20d ago
News Placeholder
Zymeworks Inc. Q4 Loss Widens
(RTTNews) - Zymeworks Inc. (ZYME) announced Loss for its fourth quarter of -$41.209 million...
Nasdaq News: Markets·20d ago
News Placeholder
Zymeworks Secures $250 Mln Royalty Funding Deal With Royalty Pharma
(RTTNews) - Zymeworks Inc. (ZYME), a clinical-stage biopharmaceutical company, on Monday entered into a $250 million royalty funding agreement with Royalty Pharma plc (RPRX), a buyer of...
Nasdaq News: Markets·20d ago
<
1
2
...
>

Latest ZYME News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.